- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07813078
Anti-Gravity Treadmill Gait Training for Knee Osteoarthritis
September 4, 2026 updated by: Piotr Pastyrzak, University of Rzeszow
Evaluation of the Effectiveness of Traditional Physiotherapy Supported by Gait Re-education Using the R-Force Anti-Gravity Treadmill in Patients With Knee Osteoarthritis - Randomized Clinical Trial
Purpose: The aim of the study will be to evaluate the effectiveness of traditional physiotherapy supported by gait re-education using the R-Force bodyweight-supported treadmill in improving gait parameters, range of motion, knee joint function, quality of life, and body composition in patients with knee osteoarthritis.
The study will be conducted in the form of a prospective, randomized clinical trial with participants divided into two therapeutic groups: a control group and an experimental group.
The therapeutic program will last 4 weeks and will be implemented 3 times a week.
Changes in gait parameters, range of motion, knee joint function, quality of life, and body composition will be evaluated.Material:
The study will include patients ≥ 40 years of age with knee osteoarthritis (Kellgren-Lawrence grade 2 or 3), confirmed radiologically, reporting pain lasting ≥ 3 months.
Participants (n = 80) will be randomly assigned to the control group (conventional physiotherapy) or the experimental group (conventional physiotherapy + training on the R-Force treadmill).Methods: Participants will be assessed at three time points: before the intervention (baseline), after completing the 4-week therapeutic program (postintervention), and after 8 weeks (follow-up).
The methods used will include: analysis of gait parameters on the R-Force treadmill, 6-Minute Walk Test (6MWT), Timed Up and Go (TUG) test, measurements of knee joint range of motion using a goniometer, thigh and lower leg circumference measurements, body composition analysis using the BIA method, subjective pain assessment using the Visual Analog Scale (VAS) and Laitinen scale, pressure pain threshold assessment using a digital algometer, functional assessment using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaires, quality of life assessment (WHOQOL-BREF), Hospital Anxiety and Depression Scale (HADS), as well as assessment of periarticular structures using ultrasound.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Piotr Pastyrzak, MSc
- Phone Number: 531-078-080
- Email: piotr.pastyrzak@gmail.com,
Study Locations
-
-
Podkarpackie Voivodeship
-
Sanok, Podkarpackie Voivodeship, Poland, 35-800
- Recruiting
- Centrum Rehabilitacji niemowląt, dzieci i dorosłych SensoReh Karolina Banaś - Pastyrzak,
-
Contact:
- Piotr Pastyrzak, MSc
- Phone Number: 531-078-080
- Email: piotr.pastyrzak@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Radiologically confirmed knee osteoarthritis (grade 2 or 3 according to the Kellgren-Lawrence classification).
- General health and functional status allowing participation in the physical therapy program (based on clinical assessment).
- Knee joint pain persisting for at least 3 months, with an intensity of >= 4 on the Visual Analog Scale (VAS).
- Age between 40 and 70 years.
- Ability to ambulate independently without any orthopedic assistive devices.
- Voluntary written informed consent to participate in the study.
- No medical contraindications to physical exercise.
Exclusion Criteria:
- Knee osteoarthritis grade 4 according to the Kellgren-Lawrence classification or lack of radiological changes (grade 0-1).
- History of total or partial knee arthroplasty (joint replacement).
- Contraindications to body composition analysis (e.g., implanted pacemaker, electronic implants, epilepsy).
- Knee joint instability (e.g., ligamentous injury).
- Acute joint inflammation.
- Neuropathies, myopathies, or other neurological conditions affecting gait.
- Active neoplastic diseases (cancer) or advanced cardiovascular diseases.
- Participation in other clinical trials within the last 6 months.
- Participation in another physical therapy or rehabilitation program within the last 6 months.
- Planned intra-articular injections or injections received in the affected knee joint within the last 3 months.
- Regular use of analgesic or anti-inflammatory drugs (NSAIDs, corticosteroids) at doses that could affect the assessment of pain and function.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group
Patients in this group will receive a comprehensive 4-week therapeutic program, 3 times a week.
The intervention combines conventional physiotherapy with gait re-education and training on the R-Force bodyweight- supported anti-gravity treadmill.
Each therapy session will last approximately 90 minutes.
|
A standard program consisting of targeted physical exercises, range of motion improvements, and strength conditioning for patients with knee osteoarthritis.
Traditional physiotherapy will include isometric exercises, strengthening, stretching, balance exercises (with elements of proprioception training), active non-weight-bearing exercises, functional exercises, gait exercises, as well as breathing and relaxation exercises.
Gait re-education and body-weight-supported treadmill training using the R-Force anti-gravity treadmill to reduce joint loading during exercise.
|
|
Active Comparator: Control Group
Patients in this group will undergo a standard 4- week conventional physiotherapy program, 3 times a week.
Each therapy session will last approximately 90 minutes.
|
A standard program consisting of targeted physical exercises, range of motion improvements, and strength conditioning for patients with knee osteoarthritis.
Traditional physiotherapy will include isometric exercises, strengthening, stretching, balance exercises (with elements of proprioception training), active non-weight-bearing exercises, functional exercises, gait exercises, as well as breathing and relaxation exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in knee joint function and symptoms using the KOOS questionnaire.
The questionnaire assesses 5 subscales: Pain, Symptoms, Activities of Daily Living, Sport and Recreation Function, and Knee-related Quality of Life.
Scores range from 0 to 100, where 100 indicates no symptoms and 0 indicates extreme symptoms.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Gait Parameters - Stride Length
Time Frame: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in mean stride length (measured in centimeters) during treadmill walking, evaluated using the built-in spatio-temporal analysis system of the R-Force treadmill.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Pain Assessment using Visual Analog Scale (VAS)
Time Frame: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in self-reported knee pain intensity during movement using a 100 mm Visual Analog Scale, where 0 mm represents "no pain" and 100 mm represents "worst imaginable pain"
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Functional Walking Capacity via 6-Minute Walk Test (6MWT)
Time Frame: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in the maximum distance (measured in meters) that a participant can walk quickly on a flat, hard surface in a period of 6 minutes.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Mobility and Balance via Timed Up and Go (TUG) Test
Time Frame: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in the time (measured in seconds) taken by a participant to rise from a chair, walk 3 meters, turn around, walk back to the chair, and sit down.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Knee Joint Range of Motion (ROM)
Time Frame: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in active and passive knee joint flexion and extension angles, measured in degrees using a standard universal goniometer
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Pressure Pain Threshold (PPT)
Time Frame: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in pressure pain threshold at standardized periarticular sites around the knee, measured in kilograms per square centimeter (kg/cm2) using a digital pressure algometer.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Ultrasound Assessment of Periarticular Structures
Time Frame: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in structural features of periarticular tissues (such as joint effusion volume, synovial thickness, or tendon presentation) evaluated qualitatively and quantitatively via knee ultrasonography
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 5, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
June 30, 2027
Study Registration Dates
First Submitted
September 4, 2026
First Submitted That Met QC Criteria
September 4, 2026
First Posted (Actual)
September 10, 2026
Study Record Updates
Last Update Posted (Actual)
September 10, 2026
Last Update Submitted That Met QC Criteria
September 4, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Resolution No. 4/12/2025/W
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be made publicly available due to institutional data protection regulations, patient privacy restrictions, and the scope of the doctoral research project.
Aggregate data and study findings will be disseminated exclusively through peer-reviewed scientific publications and conference presentations
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.